Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

EPA Reaffirms Improved Biosafety for Select Agents

by Global Biodefense Staff
November 10, 2014

U.S. Environmental Protection AgencyAs a result of a series of recent laboratory safety and security incidents that were reported at U.S. government facilities in the Summer of 2014, the White House directed federal departments and agencies to review laboratory biosafety and biosecurity best practices and protocols, as well as complete a sweep of facilities to ensure that Biological Select Agents and Toxins (BSAT) and other infectious or toxic materials are appropriately accounted for and stored.

The U.S. Environmental Protection Agency (EPA), which completed a sweep of all EPA laboratory facilities during September 2014, recently declared that no unregistered BSAT materials were found during this event.

The agency has also issued a request to all state, public, university or private laboratories, with which they partner, to participate in similar enhanced laboratory safety activities.

Examples of enhanced laboratory safety activities outlined by the EPA include:

  • Sweep of areas used to store human, animal or plant infectious agents or toxins, especially areas containing historical collections to ensure that no unregistered Biological Select Agents or Toxins (BSAT) are present.
  • Review procedures for biosafety, biosecurity, and inventory management.
  • Brainstorm activities with laboratory leadership and employees to enhance the facility biosafety culture.
  • Conduct facility biosafety training sessions.
  • Complete safety assessments or mock emergency response activities.

The EPA request encouraged partner entities to remain vigilant in on-going biosecurity efforts.

Tags: BiosafetyDual Use Research of Concern (DURC)

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks
Pathogens

NIH Grant Awarded to Study Evolution of Lyme Disease Bacteria in Deer Ticks

December 7, 2022
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC